Journals / Türk Kardiyoloji Derneği Arşivi / 2004 / Cilt: 32 - Sayı: 8

P wave duration and P wave dispersion in hyperthyroidism: Effect of antithyroid treatment

Hipertiroidide P dalga süresi ve P dalga dispersiyonu: Antitiroid tedavinin etkisi

Pages
556–563
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

P max values were found to be significantly longer in both PAF+ (114.8±11.6 ms) and PAF- (105.6±11ms) patient groups as compared to controls (91±7.6 ms; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Atrial fibrillation is frequently encountered in patients with hyperthyroidism.
📊
Key Findings & Data:Previously, it was shown that prolonged maximum P wave duration and increased P wave dispersion on 12-lead surface electrocardiograms (ECG) are closely related to the development of paroxysmal atrial fibrillation (PAF).
💡
Conclusion & Impact:P max values were found to be significantly longer in both PAF+ (114.8±11.6 ms) and PAF- (105.6±11ms) patient groups as compared to controls (91±7.6 ms; p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Atrial fibrillation is frequently encountered in patients with hyperthyroidism. Previously, it was shown that prolonged maximum P wave duration and increased P wave dispersion on 12-lead surface electrocardiograms (ECG) are closely related to the development of paroxysmal atrial fibrillation (PAF). In this study, these P wave parameters were measured from 12-lead surface ECG in hyperthyroid patients with or without PAF during sinus rhythm and compared to euthyroid controls. In addition, influence of pharmacologic antithyroid therapy on these P wave parameters was investigated. Fifty-two hyperthyroid patients were included in the study. All patients underwent 24-hour Holter recordings and then, patients were divided into two groups according to the presence (PAF+; n=29) or absence (PAF-; n=23) of PAF. Maximum P wave duration (P max), minimum P wave duration (P min) were measured from the 12-lead surface ECG and P dispersion (PWD=P max-P min) values were then calculated. P max values were found to be significantly longer in both PAF+ (114.8±11.6 ms) and PAF- (105.6±11ms) patient groups as compared to controls (91±7.6 ms; p

Özet

Hipertiroidi hastalarında atriyal fibrilasyona (AF) normal popülasyona göre daha sık rastlanmaktadır. On iki derivasyonlu yüzey elektrokardiyogramından (EKG) hesaplanan maksimum P dalga süresive P dalga dispersiyonunun (PDD) uzamasının, paroksismal atriyal fibrilasyon (PAF) gelişimi ile yakından ilişkili olduğu bilinmektedir. Bu çalışmada, hipertiroidi tanısı almış PAF'ı olan ve olmayan hastalarda bu P dalga parametreleri, ötiroid sağlıklı bireylerle karşılaştırılmıştır. Ayrıca antitiroid tedavi sonrası bahsedilen P dalga parametrelerindeki değişim incelenmiştir. Çalışmamıza 52 ardışık hipertiroidi tanısı alan hasta dahil edildi. Tüm hastaların 24 saatlik Holter kayıtları alındı ve PAF varlığına göre bu hastalar iki gruba ayrıldı (PAF+ 29 hasta, PAF- 23 hasta). Tüm hastaların maksimum P dalga süresi (P mak), minimum P dalga süresi (P min) 12-derivasyonlu yüzey EKG kayıtlarından ölçüldü. PDD, P mak'dan P min çıkarılarak hesaplandı. Bulgularımıza göre hem PAF+ hem de PAF- hipertiroidi grubunun P mak değerlerinin kontrol grubundan daha uzun olduğu saptandı (sırasıyla, 114.8±11.6 msn; 105.6±11msn; 91±7.6 msn, p

🔖

Cite This Article

GÜRAY, Ü., ALTAY, H., GÜRAY, Y., GÜLER, S., KISACIK, H., KORKMAZ, Ş., YILMAZ, M. B. (2022). P wave duration and P wave dispersion in hyperthyroidism: Effect of antithyroid treatment. Türk Kardiyoloji Derneği Arşivi, Cilt: 32 - Sayı: 8, 556–563. https://ajindex.com/articles/628649

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Klein I: Thyroid hormone and the cardiovascular system. Am J Med 1990
  2. 7 2. Sawin CT, Geller A, Wolf PA, et al: Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994
  3. 52 3. Forfar JC, Miller HC, Toft AD: Occult thyrotoxicosis: a reversible cause of "idiopathic" atrial fibrillation. Am J Cardiol 1979
  4. 12 4. Gilligan DM, Ellenbogen KA, Epstein AE: The management of atrial fibrillation. Am J Med 1996
  5. 21 5. Nordyke RA, Gilbert FI Jr, Harada ASM: Graves' disease: influence of age on clinical findings. Arch Intern Med 1988
  6. 31 6. Krahn AD, Klein GJ, Kerr CR, et al: How useful is thyroid function testing in patients with recent-onset atrial fibrillation? Arch Intern Med 1996
  7. 4 7. Nakazawa HK, Sakurai K, Hamada N, Momotani N, Ito K: Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 1982
  8. 6 8. Klein I, Ojamaa K: Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am 1998
  9. 62 9. Sandler G, Wilson GM: The nature and prognosis of heart disease in thyrotoxicosis: a review of 150 patients treated with 131 I. Q J Med 1959
  10. 69 10. Cosio FG, Palacios J, Vidal JM, Cocina EG, Gomez-Sanchez MA, Tamargo L: Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol 1983
  11. 30 11. Simpson RJ, Foster JR, Gettes LS: Atrial excitability and conduction defect. Am J Cardiol 1982
  12. 7 12. Dilaveris PE, Gialafos EJ, Sideris SK, et al: Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998
  13. 8 13. Spach MS, Miller WT, Geselowitz DB, Barr RC, Kootsey JM, Johnson EA: The discontinuous nature of propagation in normal canine cardiac muscle: evidence for recurrent discontinuity of intracellular resistance that effect the membrane currents. Circ Res 1981
  14. 54 14. Spach MS, Dolber PC: Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle: evidence for electrical uncoupling of side-side fiber connections with increased age. Circ Res 1986
  15. 71 15. Aytemir K, Özer N, Atalar E, et al: P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. PACE 2000
  16. 12 16. Ciaroni S, Cuenoud L, Bloch A: Clinical study to investiga